These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36757576)

  • 1. Essential thrombocytosis: diagnosis, differential diagnosis, complications and treatment considerations of relevance for a cardiologist.
    Kuipers RS; Kok L; Virmani R; Tefferi A
    Neth Heart J; 2023 Oct; 31(10):371-378. PubMed ID: 36757576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythromelalgic, thrombotic and haemorrhagic manifestations of thrombocythaemia.
    van Genderen PJ; Michiels JJ
    Presse Med; 1994 Jan; 23(2):73-7. PubMed ID: 8140075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and laboratory assessment of a patient with thrombocytosis.
    Appleby N; Angelov D
    Br J Hosp Med (Lond); 2017 Oct; 78(10):558-564. PubMed ID: 29019736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management.
    Tefferi A; Barbui T
    Am J Hematol; 2017 Jan; 92(1):94-108. PubMed ID: 27991718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do we need antiplatelet therapy in thrombocytosis? Pro. Diagnostic and pathophysiologic considerations for a treatment choice.
    Alberio L
    Hamostaseologie; 2016 Nov; 36(4):227-240. PubMed ID: 25707870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2013 Jun; 88(6):507-16. PubMed ID: 23695894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential Thrombocytosis in Patients <40 Years Old With Acute Coronary Syndromes: A Not So Uncommon Underlying Diagnosis Often Overlooked.
    Kok L; Taverne LF; Verbeek EC; van de Wetering M; Voogel AJ; Oosterom L; Herrman JR; Kuipers RS
    Cureus; 2022 Dec; 14(12):e32638. PubMed ID: 36654555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-mediated microvascular inflammation and thrombosis in thrombocythemia vera: a distinct aspirin-responsive arterial thrombophilia, which transforms into a bleeding diathesis at increasing platelet counts.
    Michiels JJ
    Pathol Biol (Paris); 2003 Apr; 51(3):167-75. PubMed ID: 12781799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No treatment for low-risk thrombocythaemia: results from a prospective study.
    Ruggeri M; Finazzi G; Tosetto A; Riva S; Rodeghiero F; Barbui T
    Br J Haematol; 1998 Dec; 103(3):772-7. PubMed ID: 9858229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera.
    Michiels JJ; Berneman ZN; Schroyens W; Van Vliet HH
    Platelets; 2004 Mar; 15(2):67-84. PubMed ID: 15154599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of thrombosis in essential thrombocythemia and polycythemia vera.
    Pearson TC
    Semin Oncol; 2002 Jun; 29(3 Suppl 10):16-21. PubMed ID: 12096353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approach to patients with essential thrombocythaemia and very high platelet counts: what is the evidence for treatment?
    Falchi L; Bose P; Newberry KJ; Verstovsek S
    Br J Haematol; 2017 Feb; 176(3):352-364. PubMed ID: 27984634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of thrombosis with increased platelet turnover in thrombocytosis.
    Rinder HM; Schuster JE; Rinder CS; Wang C; Schweidler HJ; Smith BR
    Blood; 1998 Feb; 91(4):1288-94. PubMed ID: 9454759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should a platelet limit of 600 x 10(9)/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages.
    Lengfelder E; Hochhaus A; Kronawitter U; Höche D; Queisser W; Jahn-Eder M; Burkhardt R; Reiter A; Ansari H; Hehlmann R
    Br J Haematol; 1998 Jan; 100(1):15-23. PubMed ID: 9450785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2015 Feb; 90(2):162-73. PubMed ID: 25611051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annual Clinical Updates in Hematological Malignancies: a continuing medical education series: polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2011 Mar; 86(3):292-301. PubMed ID: 21351120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombocytosis and thrombocytopenia - background and clinical relevance].
    Wille K; Sadjadian P; Griesshammer M
    Dtsch Med Wochenschr; 2017 Nov; 142(23):1732-1743. PubMed ID: 29145678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential thrombocythemia presenting as acute coronary syndrome: case reports and literature review.
    Xiong N; Gao W; Pan J; Luo X; Shi H; Li J
    J Thromb Thrombolysis; 2017 Jul; 44(1):57-62. PubMed ID: 28285408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
    Schwarz J; Penka M; Campr V; Pospísilová D; Kren L; Nováková L; Bodzásová C; Brychtová Y; Cerná O; Dulícek P; Joniásová A; Kissová J; Korístek Z; Schützová M; Vonke I; Walterová L
    Vnitr Lek; 2011 Feb; 57(2):189-213. PubMed ID: 21416861
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.